2017
DOI: 10.23736/s0021-9509.17.10064-9
|View full text |Cite
|
Sign up to set email alerts
|

Changes in abdominal aortic aneurysm epidemiology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
8
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(13 citation statements)
references
References 0 publications
0
8
0
Order By: Relevance
“…Regarding age, our findings are compatible with other studies that also observed a predominance of surgical treatments in elderly men. 16 - 18 We noticed a decrease in the number of procedures over the years. The European literature has shown a decrease in the frequency of emergency aneurysm repairs, with an increase in elective repairs, 17 in addition to a lower prevalence of aortic aneurysms over the decades.…”
Section: Discussionmentioning
confidence: 92%
“…Regarding age, our findings are compatible with other studies that also observed a predominance of surgical treatments in elderly men. 16 - 18 We noticed a decrease in the number of procedures over the years. The European literature has shown a decrease in the frequency of emergency aneurysm repairs, with an increase in elective repairs, 17 in addition to a lower prevalence of aortic aneurysms over the decades.…”
Section: Discussionmentioning
confidence: 92%
“…During the past two decades a drop in newly discovered cases of AAA per year has been noticed, from the previous incidence of 30,1 -40 per 100.000 inhabitants to the currently estimated incidence of 13,2 -16 per 100.000 inhabitants. 2,3,4,5,6 From the moment the diagnosis of AAA is made, life expectancy is 11 years. 7 Aneurysm diameter above 5,5 cm is a threshold above which the operative treatment is recomended.…”
Section: Introductionmentioning
confidence: 99%
“…AAA is usually asymptomatic until rupture occurs. To evaluate the risk of AAA rupture early, ultrasound screening is recommended for people over 65 years of age in several countries [ 4 , 5 ]. However, no biomarker that can serve as a screening and surveillance tool for AAA in clinical practice has been made available to date.…”
Section: Introductionmentioning
confidence: 99%